Areterna LLC was founded in 2023 as a wholly owned subsidiary of Synthgene Biotechnology Co., Ltd. Areterna provides raw materials and services to support mRNA and oligonucleotide manufacturing. The company has a robust quality system and ISO9001 certification to support cGMP compliant manufacturing of mRNA raw materials that include NTPs, modified NTPs, and cap analogs. For solid-phase DNA and RNA synthesis, Areterna offers high quality phosphonamidites to support cGMP oligo manufacturing. In addition, Areterna offers custom analytical and process development services.